Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) - Total Assets
Based on the latest financial reports, Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) holds total assets worth CN¥6.39 Billion CNY (≈ $935.45 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Hunan Dajiaweikang Pharmaceutical Indust (301126) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Total Assets Trend (2019–2025)
This chart illustrates how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's total assets have evolved over time, based on quarterly financial data. Check cash flow quality index of Hunan Dajiaweikang Pharmaceutical Indust to evaluate the quality of earnings relative to operating cash generation.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's total assets of CN¥6.39 Billion consist of 62.7% current assets and 37.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 9.3% |
| Accounts Receivable | CN¥1.95 Billion | 30.7% |
| Inventory | CN¥932.63 Million | 14.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥112.49 Million | 1.8% |
| Goodwill | CN¥1.09 Billion | 17.2% |
Asset Composition Trend (2019–2025)
This chart illustrates how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Hunan Dajiaweikang Pharmaceutical Indust.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's current assets represent 62.7% of total assets in 2025, a decrease from 87.2% in 2019.
- Cash Position: Cash and equivalents constituted 9.3% of total assets in 2025, up from 8.0% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 18.0% of total assets, an increase from 1.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 30.7% of total assets.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Competitors by Total Assets
Key competitors of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Raia Drogasil S.A
SA:RADL3
|
Brazil | R$25.58 Billion |
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥11.93 Billion |
|
Empreendimentos Pague Menos S.A
SA:PGMN3
|
Brazil | R$9.81 Billion |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3
|
Brazil | R$1.95 Billion |
|
High Tide Inc
V:HITI
|
Canada | CA$346.42 Million |
|
Yifeng Pharmacy
SHG:603939
|
China | CN¥26.07 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.83 Billion |
|
Laobaixing Pharmacy
SHG:603883
|
China | CN¥19.91 Billion |
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.01 | 1.24 | 2.29 |
| Quick Ratio | 0.78 | 0.98 | 1.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥45.24 Million | CN¥779.87 Million | CN¥1.50 Billion |
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.66 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 2.6% |
| Total Assets | CN¥6.34 Billion |
| Market Capitalization | $278.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's assets grew by 2.6% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
The table below shows the annual total assets of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥6.34 Billion ≈ $927.29 Million |
+2.57% |
| 2024-12-31 | CN¥6.18 Billion ≈ $904.06 Million |
+17.06% |
| 2023-12-31 | CN¥5.28 Billion ≈ $772.29 Million |
+34.24% |
| 2022-12-31 | CN¥3.93 Billion ≈ $575.29 Million |
+31.30% |
| 2021-12-31 | CN¥2.99 Billion ≈ $438.16 Million |
+35.99% |
| 2020-12-31 | CN¥2.20 Billion ≈ $322.21 Million |
+9.27% |
| 2019-12-31 | CN¥2.02 Billion ≈ $294.86 Million |
-- |
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more